Total Funding
53
Total FundingSeries A raised
Growth Score in past quarter
pts
Heat Score 53 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
101293
Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products.
Mark Gurney: Chairman / CEO
Scott A. Reines: Chief Medical Officer
About the Company
Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products that will bring clarity of thought to people suffering from Fragile X syndrome, Alzheimer's disease, traumatic brain injury, and other brain disorders.

